Immunohistochemistry of paraffin-embedded Human colon cancer tissue using RETNLB Polyclonal Antibody at dilution 1:40
RETNLB Polyclonal Antibody
E-AB-10579
ApplicationsImmunoHistoChemistry
Product group Antibodies
TargetRETNLB
Overview
- SupplierElabscience
- Product NameRETNLB Polyclonal Antibody
- Delivery Days Customer12
- ApplicationsImmunoHistoChemistry
- Applications SupplierELISA IHC
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.3 mg/ml
- ConjugateUnconjugated
- Gene ID84666
- Target nameRETNLB
- Target descriptionresistin like beta
- Target synonymsFIZZ1, FIZZ2, HXCP2, RELM-beta, RELMb, RELMbeta, XCP2, resistin-like beta, C/EBP-epsilon regulated myeloid-specific secreted cysteine-rich protein precursor 2, colon and small intestine-specific cysteine-rich protein, colon carcinoma-related gene protein, cysteine-rich secreted A12-alpha-like protein 1, cysteine-rich secreted protein A12-alpha-like 1, cysteine-rich secreted protein FIZZ2, found in inflammatory zone 1
- HostRabbit
- IsotypeIgG
- Protein IDQ9BQ08
- Protein NameResistin-like beta
- Scientific DescriptionResistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
- Storage Instruction-20°C
- UNSPSC41116161






